Crizanlizumab

Adakveo (crizanlizumab) is a prescription biologic medication manufactured by Novartis Pharmaceuticals Corporation. It acts as a P-selectin blocker to help manage certain conditions. Administered intravenously as an injection at 10 mg/mL strength. This information was generated using AI and is provided for informational and research purposes only.